Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +11.50p +0.25% 4,676.50p 4,680.00p 4,680.50p 4,714.00p 4,643.50p 4,651.00p 1,646,666.00 16:35:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 9,229.1 393.7 34.8 135.6 27,714.05

Shire Share Discussion Threads

Showing 1976 to 1999 of 2000 messages
Chat Pages: 80  79  78  77  76  75  74  73  72  71  70  69  Older
DateSubjectAuthorDiscuss
02/3/2017
14:49
We've definitely broken out of the downtrend on the chart now. We should make progress from here.
ygor706
23/2/2017
17:42
Chart looking good now with the downtrend broken tonight after a double bottom.
ygor706
16/2/2017
15:29
http://www.proactiveinvestors.co.uk/companies/news/173264/shire-leads-the-ftse-100-as-market-reacts-positively-to-results-and-forward-guidance-173264.html
zho
16/2/2017
13:44
On a straight eps basis the 2016 results look disastrous ie down 81%. However, if you then look at the eps numbers for the fourth quarter of 2016 and multiply by four you come up with some very healthy prospective numbers for 2017. As with most pharma companies the numbers will need to be picked over by the experts but there looks to me to be a pretty good story here that is struggling to get out!
ygor706
15/2/2017
22:25
Watch Shire (SHP) closely on potential upcoming earnings-numbers surprise http://crweworld.com/article/markets/59013/notable-companies-earnings-reports-to-watch-for-thursday-february-16-2017
arnu gutierrez
13/2/2017
18:23
Results Thursday.
philo124
13/2/2017
17:53
Results out on Thursday I think. Should be an interesting week.
ygor706
07/2/2017
13:30
Nice move this morning.
philo124
07/2/2017
13:07
Shire's balance sheet positively sparkles in comparison with those of Astrazenca and GSK and its intangibles are also much smaller - although still sufficient to wipe out shareholders' funds. The latter shouldn't be an issue as long as trading and cash flow is on the front foot - which it is here. The cash balance was historically low at the end of 2015 but should pick up unless there has been a big spend on capital items. What strikes me is that the share price has basically been treading water for the past 2 1/2 years. A good set of numbers could nearly halve the PE and then I started to ask myself where Shire fits in with the other pharma big boys. I came up with the answer 'too cheap' but it's only a personal view and I'm in for the longer haul.
ygor706
07/2/2017
10:48
>>When you look at SHPG on Nasdaq it's still in a downtrend.>> Interesting. I'll check that out. >>They also have a huge amount of debt ...>> I thought they issued shares to buy Baltaxa. Will have to check that out as well.
zho
07/2/2017
10:21
I'm slightly cautious about the chart - I think it may have bottomed because of the currency (GBPUSD rate). When you look at SHPG on Nasdaq it's still in a downtrend. They also have a huge amount of debt which has to be balanced with them looking cheap on earnings. I'm still watching them but I'm 50/50 on whether to buy or not.
jamielein
07/2/2017
09:51
Looks v appealing on earnings grounds and the chart appears to have bottomed, but if pharmas come under pricing pressure from Trump then (expensive) rare disease treatments might fare poorly.
zho
25/1/2017
08:35
Bought back in, looking for £48/50.
philo124
08/12/2016
09:58
Potential for decent spikes here, but chart is on a downward trendTrump tweets don't help
mbmiah
08/12/2016
09:20
Trumpie has plans for profit gougers..
bulltradept
07/12/2016
16:39
Unencrypted Trump twitters make for feral equities.
steeplejack
07/12/2016
14:03
Looking interesting again
mbmiah
03/12/2016
21:04
Potential reaction of Shire (SHP) to analyst' perspective on its shares ( http://crweworld.com/article/markets/48005/analysts-viewpoints-atlassian-team-transocean-rig-shire-shpg-square-sq-genvec-gnvc-legal-general-group-lggny ) plus the topline data from VONVENDI trial ( http://crweworld.com/article/press-releases/48006/topline-results-of-phase-3-investigational-study-of-vonvenditm-von-willebrand-factor-recombinant-meets-primary-endpoint-effectively-controlling-bleeding-and-blood-loss-during-surgical-procedures )
arnu gutierrez
10/11/2016
10:06
Sold, £6 per share up minus costs.
philo124
09/11/2016
09:25
Got the timing right on the buy back at the mo.
philo124
09/11/2016
08:51
20% upside now Obamacare is out of the way
bigboots
07/11/2016
12:19
Bought back in this morning hoping to see £52 in due course.
philo124
01/11/2016
16:01
http://www.telegraph.co.uk/business/2016/11/01/shire-in-fine-form-and-will-shrug-off-pricing-pressure-says-chie/
zho
20/10/2016
00:13
............. Re Cancer drugs , proteomics and genomics ................. I choose them because they are where the money is at If you do some research you will find that many celebrities have undergone surgery to remove various parts of their body in order to avoid the onset of a cancer type. They have done this because they have tested positive for an inherited genetic mutated gene which recent molecular diagnostic testing has proved to be linked to certain cancer types and subsets. Thus since we all know at present no cure for any cancer using drugs exists Then this also proves that the continued development of drugs which target tumors is a waste of time re finding a cure. However some new drugs do extend life by several months eg circa from 12 months to perhaps eighteen months The quality of this extended life does not get mentioned much My point is that the rich celebrities spend money on cancer preventative operations because they have the money and specialist guidance to do so. A cure for cancer will not be found by trying to attack a developed tumor The cure will be to attack and remove the mutated genes that cause it
buywell3
Chat Pages: 80  79  78  77  76  75  74  73  72  71  70  69  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170325 17:34:17